Beckman Coulter and Molecular Devices finalize agreement for drug discovery screening systems
Beckman Coulter, Inc. and Molecular Devices Corporation announce an agreement to integrate microplate detection systems from Molecular Devices with liquid handling and Core System technology from Beckman Coulter. This partnership will significantly reduce cost and time requirements of integrating these products for customers in genetic analysis and drug discovery. Applications include DNA quantification and DNA normalization, high-throughput screening, ADME/Tox assays and basic research settings.
Products from Molecular Devices which now carry the "Core Compliant" designation include SPECTRAmax microplate spectrophotometers, SPECTRAmax GEMINI microplate spectrofluorometers, FLIPR fluorometric imaging plate readers, the Analyst and Acquest benchtop multi-mode detection instruments, and Embla microplate washers. With an integration kit from Beckman Coulter, these readers can now be easily used with the Biomek FX and Biomek 2000 Automated Liquid Handling Systems as well as on SAGIAN Core Systems.
The Core System approach, developed by Beckman Coulter, integrates an automated liquid handling system with an ever-expanding choice of "a la carte" modules and peripherals. This approach also allows for easy, cost-effective integration of additional devices.
"Molecular Devices is a clear leader in every one of their detection system technologies, making them an excellent choice as our Core partner," comments Jan Allen Pursley, Strategic Marketing Manager for Beckman Coulter. "Our robotics customers ask for integration with Molecular Devices instruments very frequently."
"We are delighted to have developed this partnership with a top robotics company such as Beckman Coulter," comments Tom Driscoll, Director of Marketing for Molecular Devices. "This agreement delivers the best of both worlds to our mutual customers, reducing the time and cost of integration for the many companies that want these two leading products."
Molecular Devices Corporation is a leading developer of high-performance, bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. Molecular Devices' systems enable pharmaceutical and biotechnology companies to leverage advances in genomics and combinatorial chemistry by facilitating the high throughput and cost effective identification and evaluation of drug candidates. Molecular Devices' instrument systems are based on its advanced core technologies which integrate its expertise in engineering, molecular and cell biology and chemistry and are fundamental tools for drug discovery and life sciences research.
Beckman Coulter is a leading provider of instrument systems and complementary products that simplify and automate processes in life science and clinical laboratories. The company's products are used throughout the world in all phases of the battle against disease, from pioneering medical research and drug discovery to diagnostic testing that aids in patient treatment. Annual sales for the company totaled $1.89 billion in 2000, with approximately half of this amount generated outside the United States.
For more information, access the Beckman Coulter World Wide Web Information Service at www.beckmancoulter.com or call (800) 742-2345 (U.S.). Fax (800) 643-4366 (U.S.). From outside the U.S. call (714) 871-4848, or Fax (714) 773-6611.
Source: Beckman Coulter
Subscribe to our free e-mail newsletter.
Click for a free Buyer's Guide listing.